Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours. (2015)
Attributed to:
Evaluation of non-invasive metabolic imaging biomarkers for novel RAF/MEK1/2-targeted anti-cancer agents
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/bjc.2015.86
PubMed Identifier: 25742484
Publication URI: http://europepmc.org/abstract/MED/25742484
Type: Journal Article/Review
Volume: 112
Parent Publication: British journal of cancer
Issue: 7
ISSN: 0007-0920